STOCK TITAN

Viatris to Host Webinar: The Power of Partnership to Address Antimicrobial Resistance

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
partnership conferences
Rhea-AI Summary
Viatris Inc. is hosting a webinar called 'The Power of Partnership to Address Antimicrobial Resistance (AMR)' on November 14, 2023. AMR is a significant threat to global health and economic development, potentially causing more deaths than HIV/AIDS and malaria worldwide. The World Health Organization estimates that deaths due to AMR could reach 10 million people a year by 2050 without action. The webinar will include discussions with experts from the AMR Industry Alliance and the University of Pennsylvania.
Positive
  • None.
Negative
  • None.

PITTSBURGH, Oct. 30, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, announced today it is hosting The Power of Partnership to Address Antimicrobial Resistance (AMR), a Nasdaq webinar that will air on Tuesday, November 14, 2023 at 9 a.m. ET.

AMR is a significant threat to global health and economic development. As the progression of AMR renders antibiotics less effective, common infections, such as wound infections, urinary tract infections, and pneumonia can increasingly be associated with severe complications and increased risk of death. AMR is a major driver of death globally, potentially accounting for more deaths than HIV/AIDS and malaria worldwide.

The World Health Organization estimates that the number of deaths due to AMR could rise to 10 million people a year by 2050 under the most alarming scenario if no action is taken. No one company or entity can tackle the issue alone. Partnerships and collaborations are critical to tackling the problem together.

Moderated by Erika Satterwhite, Head of Global Policy at Viatris, the discussion will include Melissa Gong Mitchell, Secretariat Lead for the AMR Industry Alliance, and Dr. Yehoda Martei, Assistant Professor of Medicine, and the Vice Chief of Diversity, Inclusion and Health Equity in the Division of Hematology-Oncology at the University of Pennsylvania.

Register here to join this this free webinar sponsored by Viatris Inc.  

About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life's moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter, LinkedIn, Instagram and YouTube.

Viatris Logo (PRNewsfoto/Viatris Inc.)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-host-webinar-the-power-of-partnership-to-address-antimicrobial-resistance-301970507.html

SOURCE Viatris Inc.

FAQ

What is the webinar hosted by Viatris Inc. about?

The webinar is called 'The Power of Partnership to Address Antimicrobial Resistance (AMR)' and aims to discuss the threat of AMR and the importance of partnerships in tackling the issue.

When will the webinar take place?

The webinar will air on Tuesday, November 14, 2023 at 9 a.m. ET.

Why is AMR a significant threat?

AMR renders antibiotics less effective, leading to severe complications and increased risk of death from common infections. It is a major driver of death globally.

How many deaths could be caused by AMR by 2050?

The World Health Organization estimates that deaths due to AMR could reach 10 million people a year by 2050.

Who will be participating in the webinar?

The webinar will include discussions with Melissa Gong Mitchell from the AMR Industry Alliance and Dr. Yehoda Martei from the University of Pennsylvania.

Viatris Inc.

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Stock Data

14.03B
1.18B
0.35%
83.36%
3.06%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
CANONSBURG

About VTRS

mylan is a global pharmaceutical company committed to setting new standards in healthcare. working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. we offer a growing portfolio of around 1,400 generic pharmaceuticals and several brand medications. in addition, we offer a wide range of antiretroviral therapies, upon which nearly 50% of hiv/aids patients in developing countries depend. we also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time. learn more at mylan.com.